Gprc5a identified as potential drug target for treating osteoporosis

FHS
June 18, 2024
2:34 pm

Osteoporosis is a skeletal condition that leads to the weakening of bones, making them porous, fragile, and prone to breakage.

Madrigal’s got more positive data for resmetirom, plus news from Aligos and NorthSea

The American Association for the Study of Liver Diseases is set to hold its annual Liver Meeting this weekend in Boston. This morning, we rounded

November 11, 2023

Sheba Medical Center Develops AI Algorithm to Predict Pulmonary Embolism

What You Should Know: – Sheba Medical Center, a globally recognized healthcare leader, announced the publication of a groundbreaking study demonstrating the effectiveness of an

August 13, 2024

Inulin gel-based oral immunotherapy is effective in suppressing food allergy responses and anaphylactic shock

A novel oral immunotherapy platform that uses formulated inulin gel combined with food allergens to orally deliver dietary antigens.

July 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.